
|Articles|January 7, 2014
IMS Health Files for IPO
IMS Health has filed a registration statement with the US Securities and Exchange Commission
Advertisement
IMS Health, which provides information, services and technology for the healthcare industry, that allows them to measure and improve performance, has filed a registration statement with the U.S. Securities and Exchange Commission for proposed initial public offering of its common stock.
In the clinical trials area, IMS Health acquired both DecisionView and TTC in 2012. DecisionView provided software solutions for patient enrollment in clinical trials, and TTC benchmarking and analytics solutions for negotiating costs of clinical trials through its GrantPlan database.
The full relase can be read
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
2
What Clinical Trials Can Learn from the Gig Economy About Payments
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
AI-Driven Clinical Trial Recruitment and Design
5




